Related Experiment Video
Updated: Apr 14, 2026
03:38
Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction
Published on: October 6, 2022
2.0K
Predicting the Uncertain Future of Aptamer-Based Diagnostics and Therapeutics
1Operational Technologies Corporation, 4100 NW Loop 410, Suite 230, San Antonio, TX 78229, USA. john.bruno@otcorp.com.
Molecules (Basel, Switzerland)
|April 28, 2015
Summary
Nucleic acid aptamers offer advantages over antibodies for diagnostics and therapeutics, but commercialization faces challenges due to industry focus on antibodies and lack of awareness. Future applications in infectious disease and cancer diagnostics are promising.
Area of Science:
- Biotechnology
- Molecular Diagnostics
- Therapeutics Development
Background:
- Nucleic acid aptamers possess significant potential for diagnostics and therapeutics due to ease of development and low immunogenicity.
- Commercial success of aptamer-based products is limited, hindered by established antibody markets and limited awareness of aptamer capabilities.
- Past commercialization failures have created skepticism regarding aptamers' market viability compared to monoclonal antibodies.
Purpose of the Study:
- To analyze the reasons behind the limited commercial success of aptamer-based products.
- To highlight the advantages of aptamers over antibodies in specific niche applications.
- To explore future directions and potential applications of aptamers in biomedical technology.
Main Methods:
- Review of existing literature on aptamer development, clinical trials, and market performance.
- Comparative analysis of aptamers and antibodies regarding their properties and applications.
- Examination of recent advancements in aptamer modifications and emerging applications.
Main Results:
- Despite challenges, aptamers offer unique advantages for diagnostics and therapeutics, particularly in infectious disease and cancer.
- Growing familiarity with aptamer technology is expected to increase their consideration in research and development.
- New aptamer modifications and applications show potential to revolutionize biomedical technology.
Conclusions:
- Aptamers hold significant promise for future commercial products in diagnostics and therapeutics, despite current market limitations.
- Addressing industry awareness and leveraging niche applications will be key to aptamer market growth.
- Continued research into aptamer modifications and novel applications may lead to groundbreaking biomedical innovations.
